PARANOVO

This brand name is authorized in Nigeria.

Active ingredients

The drug PARANOVO contains one active pharmaceutical ingredient (API):

1	Paracetamol UNII 362O9ITL9D - ACETAMINOPHEN
	Paracetamol is a medication used to treat pain and fever. It does appear to selectively inhibit COX activities in the brain, which may contribute to its ability to treat fever and pain.
	Read more about Paracetamol

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-3434	Injection	PARANOVO INJECTION INJ 150 mg/mL	PARANOVO INJECTION B4-3434 PARANOVO INJECTION SODIUM ACETATE (ANHYDROUS) GLACIAL ACETIC ACID BP, PROPYLANE GLYCOL BP, P. E.G 400 USP/NF SODIUM METABISULPHITE BP, SODIUM THIOSULPHATE USP, BENZLY ALCOHOL BP Prescription Only Medicine (POM) MAYDON PHARMACEUTICAL LIMITED., WILMER STREET, OFF TOWN PLANNING, ILUPEJU, LAGOS LAGOS Nitin Lifesciences Ltd., Rampur Road, Paonta Sahib Dist. Sirmour-173025, Himachal Pardesh India. , India 2/23/2023 2/22/2028	23/02/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N02BE01	Paracetamol	N Nervous system → N02 Analgesics → N02B Other analgesics and antipyretics → N02BE Anilides
Discover more medicines within N02BE01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-3434